Life Science Investing PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
Life Science Investing PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
Life Science Investing PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital
Life Science Investing Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
Life Science Investing Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
